πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 92 of 200 Β· A–Z by INN

  1. hydrocortisone valerate

    HYDROCORTISONE VALERATE

    TOPICAL FDA: approved

  2. hydroflumethiazide

    HYDROFLUMETHIAZIDE AND RESERPINE

    ORAL FDA: approved

  3. hydrogen

    NMPA: clinical trials

  4. hydrogen peroxide

    ESKATA Aclaris Therapeutics

    TOPICAL FDA: approved

  5. hydromorphone

    DILAUDID Lacuna Pharma Pty Ltd

    TGA: approved Β· NMPA: clinical trials

  6. hydromorphone hydrochloride

    HYDROMORPHONE HYDROCHLORIDE

    INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS FDA: approved

  7. hydronidone

    NMPA: clinical trials

  8. hydrotalcite

    NMPA: clinical trials

  9. hydroxocobalamin

    COBAL-B12 Pfizer Australia Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved

    V03AB33
  10. hydroxyamphetamine hydrobromide

    PAREDRINE

    OPHTHALMIC FDA: approved

  11. hydroxybenzoate compound solution

    NULL

    TGA: approved

  12. hydroxycarbamide

    HYDREA

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01XX05
  13. hydroxychloroquine

    APO- HYDROXYCHLOROQUINE Sanofi-aventis Healthcare Pty Ltd

    TGA: approved Β· NMPA: clinical trials

  14. hydroxychloroquine sulfate

    HYDROXYCHLOROQUINE SULFATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  15. hydroxyethyl starch 130/0.4 + sodium chloride

    VOLUVEN 6% Fresenius Kabi Australia Pty Limited

    TGA: approved

  16. hydroxyprogesterone caproate

    HYDROXYPROGESTERONE CAPROATE

    INTRAMUSCULAR FDA: approved

  17. hydroxypropyl cellulose

    LACRISERT

    OPHTHALMIC FDA: approved

  18. hydroxystilbamidine isethionate

    HYDROXYSTILBAMIDINE ISETHIONATE

    INJECTION FDA: approved

  19. hydroxyurea

    HYDROXYUREA

    ORAL FDA: approved

  20. hydroxyzine hydrochloride

    HYDROXYZINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  21. hydroxyzine pamoate

    HYDROXYZINE PAMOATE Teva Pharma GmbH

    ORAL FDA: approved

  22. hyoscine butylbromide

    BUSCOPAN Sanofi-aventis Healthcare Pty Ltd

    TGA: approved

  23. hypromellose

    REVIVE TEARS Alphapharm Pty Ltd

    TGA: approved

  24. ianalumab

    NMPA: clinical trials

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources